Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 15;33(4):555-557.
doi: 10.1093/bioinformatics/btw674.

INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery

Affiliations

INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery

Jin Zhang et al. Bioinformatics. .

Abstract

Motivation: While high-throughput sequencing (HTS) has been used successfully to discover tumor-specific mutant peptides (neoantigens) from somatic missense mutations, the field currently lacks a method for identifying which gene fusions may generate neoantigens.

Results: We demonstrate the application of our gene fusion neoantigen discovery pipeline, called INTEGRATE-Neo, by identifying gene fusions in prostate cancers that may produce neoantigens.

Availability and implementation: INTEGRATE-Neo is implemented in C ++ and Python. Full source code and installation instructions are freely available from https://github.com/ChrisMaherLab/INTEGRATE-Neo .

Contact: christophermaher@wustl.edu.

Supplementary information: Supplementary data are available at Bioinformatics online.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Overview of INTEGRATE-Neo. Green box is data, and blue box is a module

Similar articles

Cited by

References

    1. Andreatta M., Nielsen M. (2016) Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics, 32, 511–517. - PMC - PubMed
    1. Carreno B.M. et al. (2015) Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science, 348, 803–808. - PMC - PubMed
    1. Gubin M.M. et al. (2014) Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature, 515, 577–581. - PMC - PubMed
    1. Heemskerk B. et al. (2013) The cancer antigenome. EMBO J., 32, 194–203. - PMC - PubMed
    1. Hundal J. et al. (2016) pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens. Genome Med., 8, 11. - PMC - PubMed

Substances